Citation
Sm. Thomas et Jf. Burke, GLAXO-WELLCOME - TOP OF THE CLASS FOR SMALL MOLECULES - WHERE IN GENOMICS, Expert opinion on therapeutic patents, 8(2), 1998, pp. 103-109
Citations number
1
Categorie Soggetti
Medicine, Legal","Pharmacology & Pharmacy
Journal title
ISSN journal
13543776
Volume
8
Issue
2
Year of publication
1998
Pages
103 - 109
Database
ISI
SICI code
1354-3776(1998)8:2<103:G-TOTC>2.0.ZU;2-C
Abstract
Before its merger, the Glare group had a surprisingly small number of
patented DNA molecules in its portfolio. This is in contrast to The We
llcome Foundation, which had over 40 patents mainly for the production
of reagents for diagnostic kits and also for gene therapy. It is too
early to determine the merged Company's patent strategy in the area of
genomics and gene analysis.